Guidance
Organ specific guidance
- Guidance for Adult Heart Exception Requests (Status 2 Cardiogenic Shock Candidates) (PDF - 449 K; 2/2021) Effective 2/09/2021
- Guidance for Pediatric Heart Exception Requests (PDF - 620 K) Effective 2/09/2021
- Review board guidance for HCM/RCM exception requests (PDF - 674 K; 10/2018) Effective 10/18/2018
- Review board guidance for adult CHD exception requests (PDF - 180 K; 12/2017)
- Benefits of pancreas after kidney transplantation
(PDF - 505 K; 12/2017) - Pancreas allocation system introduction
Other guidance
- Procedures to collect post-donation follow-up data from living donors
- Recognizing seasonal and geographically endemic infections in living donors (11/2014)
- Identifying risk factors for West Nile Virus in living donors (6/2013)
- Identifying risk factors for Mycobacterium tuberculosis (MTB) in living kidney donors (11/2012)
- Optimizing VCA recovery from deceased donors (PDF - 492 K; 6/2018)
- VCA deceased donor authorization (PDF - 202K)
- Guidance addressing blood type determination (6/2020)
- ABO sub-typing of blood-type A and B organ donors (PDF - 502 K; 6/2018)
- Identifying risk factors for West Nile Virus in living donors (6/2013)
- HTLV-1 screening and reporting (2/2014)
- Recognizing central nervous system infections (2/2014)
- Recognizing seasonal and geographically endemic infections in living donors (11/2014)
- Effective practices in broader distribution (PDF - 727 K; 6/2019)
- Pediatric transition and transfer guidance (PDF; 12/2018)
- Guidance on requested deceased donor information (PDF - 197 K; 6/2018)
- Histocompatibility lab policy and bylaws guidance (6/2017)
- Donor and recipient information sharing (1/2011)
- Patient information letter